Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca D Dodd

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Plos One|December 4, 2009
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytomaJeffrey K Mito, Richard F Riedel, Leslie Dodd, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2025
Retraction notice to "Efficacy of Sunitinib and Radiotherapy in Genetically Engineered Mouse Model of Soft-Tissue Sarcoma" Int J Radiat Oncol Biol Phys, 2009; 74(4), pp 1207-1216Sam S Yoon, Lars Stangenberg, Yoon-Jin Lee, et al.
Cancer|March 23, 2012
Intraoperative detection and removal of microscopic residual sarcoma using wide-field imagingJeffrey K Mito, Jorge M Ferrer, Brian E Brigman, et al.
International Journal of Radiation Oncology, Biology, Physics|June 24, 2009
Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcomaSam S Yoon, Lars Stangenberg, Yoon-Jin Lee, et al.
Plos One|September 17, 2013
Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cellsLaura M Epple, Rebecca D Dodd, Andrea L Merz, et al.
Frontiers in Immunology|July 24, 2024
Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumorsSiddhi N Paudel, Brian J Hutzen, Katherine E Miller, et al.
Frontiers in Immunology|July 24, 2024
Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumorsSiddhi N Paudel, Brian J Hutzen, Katherine E Miller, et al.
Plos One|September 2, 2016
X-Ray Psoralen Activated Cancer Therapy (X-PACT)Mark Oldham, Paul Yoon, Zak Fathi, et al.
Cancer Research|May 4, 2018
Genomic Status of <i>MET</i> Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath TumorsJacqueline D Peacock, Matthew G Pridgeon, Elizabeth A Tovar, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Intratumoral plasma cells mediate CD8+ T cell infiltration and successful immune checkpoint blockade therapy in <i>de novo</i> MPNSTsJoshua J Lingo, Ryan Reis, Chantal Allamargot, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Plos One|December 4, 2009
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytomaJeffrey K Mito, Richard F Riedel, Leslie Dodd, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2025
Retraction notice to "Efficacy of Sunitinib and Radiotherapy in Genetically Engineered Mouse Model of Soft-Tissue Sarcoma" Int J Radiat Oncol Biol Phys, 2009; 74(4), pp 1207-1216Sam S Yoon, Lars Stangenberg, Yoon-Jin Lee, et al.
Cancer|March 23, 2012
Intraoperative detection and removal of microscopic residual sarcoma using wide-field imagingJeffrey K Mito, Jorge M Ferrer, Brian E Brigman, et al.
International Journal of Radiation Oncology, Biology, Physics|June 24, 2009
Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcomaSam S Yoon, Lars Stangenberg, Yoon-Jin Lee, et al.
Plos One|September 17, 2013
Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cellsLaura M Epple, Rebecca D Dodd, Andrea L Merz, et al.
Frontiers in Immunology|July 24, 2024
Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumorsSiddhi N Paudel, Brian J Hutzen, Katherine E Miller, et al.
Frontiers in Immunology|July 24, 2024
Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumorsSiddhi N Paudel, Brian J Hutzen, Katherine E Miller, et al.
Plos One|September 2, 2016
X-Ray Psoralen Activated Cancer Therapy (X-PACT)Mark Oldham, Paul Yoon, Zak Fathi, et al.
Cancer Research|May 4, 2018
Genomic Status of <i>MET</i> Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath TumorsJacqueline D Peacock, Matthew G Pridgeon, Elizabeth A Tovar, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Intratumoral plasma cells mediate CD8+ T cell infiltration and successful immune checkpoint blockade therapy in <i>de novo</i> MPNSTsJoshua J Lingo, Ryan Reis, Chantal Allamargot, et al.
Pageof 6